| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +81,566 | 25% | $21.67 | +$1,767,823 |
| Sells | 4 | -247,407 | 75% | $23.82 | -$5,893,671 |
| Net | 0 | -165,841 | -50% | -$4,125,849 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. | 10%+ Owner | $80,882,421 | 10 Jun 2024 | ||
| ARCH Venture Partners XII, LLC | 10%+ Owner | $37,212,805 | 10 Jun 2024 | ||
| JAMES HEALY | Director | $19,916,028 | 17 Jun 2025 | ||
| Abraham Ceesay | Chief Executive Officer, Director | $19,354,597 | -$3,496,925 | -15% | 18 Feb 2026 |
| Krishnaswamy Yeleswaram | Chief Development Officer | $8,924,579 | -$85,342 | -0.95% | 02 Feb 2026 |
| Cheryl Gault | Chief Operating Officer | $5,174,568 | -$150,487 | -2.8% | 02 Feb 2026 |
| Bradley S. Galer | Chief Medical Officer | $1,970,311 | 06 Jun 2024 | ||
| STEVEN M. PAUL | Director | $1,040,450 | +$1,027,111 | +7700% | 12 Sep 2025 |
| David Bredt | Chief Scientific Officer | $707,535 | -$2,160,917 | -75% | 17 Feb 2026 |
| Reid M. Huber | Director | $499,373 | +$499,374 | 12 Sep 2025 | |
| Wendy B. Young | Director | $214,700 | +$140,350 | +189% | 11 Sep 2025 |
| Troy A. Ignelzi | Chief Financial Officer | $99,800 | +$100,988 | 02 Feb 2026 | |
| Ramiro Sanchez | Director | 17 Jun 2025 | |||
| Paul M. Silva | Director | 17 Jun 2025 | |||
| JOHN MARAGANORE | Director | 17 Jun 2025 | |||
| Jeffrey Sevigny | Chief Medical Officer | 02 Feb 2026 | |||
| Jeffrey K. Tong | Director | 06 Jun 2024 | |||
| Terry-Ann Burrell | Director | 06 Jun 2024 | |||
| ROBERT J. PEREZ | Director | 17 Jun 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|